INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,444,005 | -22.5% | 77,293 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $3,152,009 | -82.0% | 77,293 | -68.0% | 0.01% | -80.8% |
| Q1 2022 | $17,542,000 | -60.1% | 241,396 | -33.4% | 0.03% | -58.1% |
| Q4 2021 | $43,937,000 | -9.6% | 362,396 | 0.0% | 0.06% | -19.5% |
| Q3 2021 | $48,615,000 | -17.1% | 362,396 | 0.0% | 0.08% | -18.9% |
| Q2 2021 | $58,676,000 | +101.7% | 362,396 | 0.0% | 0.10% | +79.2% |
| Q1 2021 | $29,084,000 | – | 362,396 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |